Page last updated: 2024-09-04

cyc 202 and Rheumatoid Arthritis

cyc 202 has been researched along with Rheumatoid Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Buckley, CD; Cole, M; Cranston, A; Filer, A; Frame, S; Isaacs, JD; McInnes, IB; Morton, M; Ng, WF; Pratt, AG; Siebert, S; Stocken, DD	1

Trials

1 trial(s) available for cyc 202 and Rheumatoid Arthritis

Article	Year
Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial. Medicine, 2020, Jun-26, Volume: 99, Issue:26 Topics: Abatacept; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Humans; Maximum Tolerated Dose; Multicenter Studies as Topic; Protein Kinase Inhibitors; Roscovitine; Tumor Necrosis Factor Inhibitors; United Kingdom	2020

Article

Year

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial.

Medicine, 2020, Jun-26, Volume: 99, Issue:26

Topics: Abatacept; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Humans; Maximum Tolerated Dose; Multicenter Studies as Topic; Protein Kinase Inhibitors; Roscovitine; Tumor Necrosis Factor Inhibitors; United Kingdom

2020